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1406Idiopathic dilated cardiomyopa-
thy (DCM) is a disease of the
heart muscle characterized by
ventricular chamber enlargement
and systolic dysfunction (1,2).
The prognosis is usually poor,
but some patients do recover
normal cardiac function. Studies
in both adults and children have
reported recovery of cardiac
function in 21% to 37% of pa-
tients, as indicated by serial
echocardiograms (3–5). SurvivalSee page 1414of adults with idiopathic DCM has improved in recent
decades, with more than half surviving for 10 years (5,6).
Although risk factors for death or transplantation in children
with idiopathic DCM are well-studied, predictors of
normalization are largely unknown (7–10). With additional
medical therapies being used for heart failure in children, as
well as a marked increase in the use of ventricular assist
devices, identifying predictors of recovering cardiac function
is of particular importance.
We studied children with idiopathic DCM who had
echocardiographic data sufﬁcient to assess recovery of
normal LV function and size. We identiﬁed the proportion
of these children who regained normal echocardiographic
measurements in the large, multicenter, National Heart,
Lung, and Blood Institute–funded Pediatric Cardiomyopa-
thy Registry (PCMR) (11,12). We sought to identify the
clinical characteristics at presentation that predict echocar-
diographic normalization within 2 years. Additionally, we
report longer-term follow-up data in children whose LV
function and size returned to normal within 2 years of
diagnosis to examine the permanence of recovery.Methods
Study design. The design and conduct of the PCMR are
detailed elsewhere (13,14). Institutional review board
approval of the PCMR protocol was obtained from all
participating centers. From 1990 to 2012, the PCMR
enrolled more than 3,000 children <18 years of age in whom
cardiomyopathy was diagnosed at any of 98 pediatric cardiac
centers in the United States and Canada. The data in the
PCMR database current as of January 14, 2013, were
analyzed.
Patient classiﬁcation. The PCMR diagnostic criteria for
pure DCM (13,14) are based on strict echocardiographic
measurements related to left ventricular (LV) enlargement
and depressed function; pathologic ﬁndings at autopsy or by
endomyocardial biopsy; or clinical evidence from the diag-
nosing physician. We studied only children with idiopathic
DCM, deﬁned as DCM of unknown cause at the timeof diagnosis (1,6,9). Children who were classiﬁed at pre-
sentation by the clinical investigators as having neuromus-
cular disease, familial cardiomyopathy, metabolic or
mitochondrial disorder, or myocarditis on the basis of the
presentation of new-onset cardiac symptoms and/or echo-
cardiographic abnormalities developing after a history of
recent infection with or without evidence of myocarditis on
endomyocardial biopsy were excluded (4). Additionally, to
examine recovery of normal LV function and size in a ho-
mogeneous group, the sample was restricted to children who
had both LV dilation (i.e., LV end-diastolic dimension
[EDD] >2 SD above normal for body surface area) and
depressed LV systolic function (LV fractional shortening
[FS] or LV ejection fraction [EF] >2 SD below normal for
age) at diagnosis. Echocardiographic outcomes were deter-
mined only in children with echocardiographic data on
function and size both at diagnosis and at follow-up within 2
years. A minimum interval of 30 days between the ﬁrst and
subsequent echocardiograms was used to classify children
into 2 groups: 1) those with persistently abnormal echo-
cardiograms; and 2) those who recovered normal LV size
and function. Figure 1 details the composition of the ana-
lytic cohort. Echocardiographic data beyond 2 years was not
sufﬁciently complete to uniformly assess a longer follow-up
period for recovering normal echocardiographic function
and size. However, long-term follow-up data regarding
death or heart transplantation outside the 2-year window,
where available, are reported for each group.
Data collection. Patient age, race, sex, weight, height, and
body surface area were collected at diagnosis. Clinical evi-
dence of congestive heart failure and echocardiographic
measurements of LVEDD, left ventricular end-systolic
dimension (LVESD), LVFS, LV septal and posterior wall
thicknesses, and LV mass were also collected at diagnosis
and annually thereafter. Values for LV measurements are
expressed as z-scores to adjust for the effect of body size
and age. The z-score is the number of SDs from the mean
value at a given body surface area in a distribution of a large
population of normal children. The z-score for the mean of
this population distribution is 0, and the normal range is
typically deﬁned as –2 to þ2 SD (10).
Statistical methods. The Data Coordinating Center at the
New England Research Institutes, Watertown, Massachu-
setts, performed all data analyses. Summary statistics are
presented as mean  SD or as median and interquartile
range for continuous variables and as percentages for cate-
gorical variables. Changes in echocardiographic measures
obtained at diagnosis and follow-up were compared using a
paired Student t test. Patient characteristics among the 3
groups were compared with analysis of variance or the
Kruskal-Wallis test for continuous variables and a Fisher
exact test for categorical variables.
We used nonparametric competing-risks methodology to
estimate the cumulative incidence rates of echocardiographic
normalization versus death or transplantation versus persis-
tent abnormal LV size or function (15). Risk factors for the
Figure 1 Echocardiographic Normalization in Children With Idiopathic DCM (N ¼ 741)
Sample selection to identify echocardiographic normalization in children with idiopathic dilated cardiomyopathy (DCM). FS ¼ fractional shortening; LVEDD ¼ left ventricular
end-diastolic dimension.
JACC Vol. 63, No. 14, 2014 Everitt et al.
April 15, 2014:1405–13 Recovery of Echo Function in Pediatric Dilated Cardiomyopathy
1407outcome of echocardiographic normalization in the presence
of death or transplantation as a competing risk were also
identiﬁed using this methodology. Candidate predictors for
the multivariate model were variables with a univariate
p value <0.2 and had few missing data. A p value <0.05
was considered to be statistically signiﬁcant. All analyses
were conducted using SAS version 9.3 (SAS Institute Inc.,
Cary, North Carolina) or R version 2.14.1 (R Foundation
for Statistical Computing, Vienna, Austria), including the
cmprsk library.Results
Among 1,388 children with idiopathic DCM diagnosed
between 1990 and 2012, 868 met the echocardiographic
inclusion criteria of both depressed LV systolic function
and LV dilation (Fig. 1). Of these, 741 (85%) had sufﬁ-
cient follow-up data 30 days to 2 years following diagnosis
and were included in the analysis. The 127 with insufﬁ-
cient follow-up data were slightly older at diagnosis
(median [interquartile range]: 2.0 [0.6 to 8.4] years vs. 1.0
[0.3 to 8.1] years; p ¼ 0.01). Of the 741 in the analytic
cohort, 96 were classiﬁed as achieving normalization of
LV size and function on the basis of echocardiographic
data, 317 died or underwent heart transplantation, and
328 were classiﬁed as having persistently abnormal LV
size and/or function.
Patient characteristics. Children with normal echocardio-
grams within 2 years after diagnosis were younger at diag-
nosis (Table 1). The normalized group had less LV dilation
at diagnosis and a higher mean fractional shortening z-score
than did the persistently abnormal group and the death/
heart transplantation group (Table 2).In the normalized group, mean LV size, which was more
than 4 SD above normal at diagnosis, had a mean z-score of
–0.06 on follow-up echocardiography, and the fractional
shortening z-score improved from a mean of –9.21 to close
to zero (–0.08). In absolute terms, mean LV fractional
shortening increased from 15% to 37%. In the death/
transplantation group, baseline and follow-up echocardio-
graphic measurements for LV size and function did not
change. In the persistently abnormal group, LV function
improved slightly and LV size and mass decreased, but not
enough to be considered normal (Table 3).
Outcomes. During the 2-year follow-up period, 22% of
children had echocardiographic evidence of both normal LV
function and size. The cumulative incidences of the 3
competing outcomes (echocardiographic normalization,
death/transplantation, and persistently abnormal LV func-
tion or LV dilation) are shown in Figure 2. In the 96 chil-
dren with normal LV function and size during the 2-year
period, the median time to recovering normal echocardio-
graphic function and size was 9.5 months. Seven of these
children subsequently underwent heart transplantation. The
time interval between the echocardiogram showing normal
LV size and function and heart transplantation was between
2 weeks and 10 months in 6 children and 1.75 years in
1 child. Two additional children died at 3.4 and 10.8 years
after diagnosis. A subset (n ¼ 51) of the remaining
normalized cases had echocardiographic data later than 2
years. Ten (20%) had follow-up measurements that indi-
cated only abnormal LV size or function but not both.
In the 328 children who had persistently abnormal
echocardiograms within 2 years of diagnosis, the mean 
SD time from diagnosis to the latest echocardiogram
within the 2-year period was 16  7 months. In this group,
Table 1
Characteristics of Children With Idiopathic DCM at Diagnosis (N ¼ 741), by
Echocardiographic Status or Clinical Outcome Within 2 Years After Diagnosis
Normalized
(n ¼ 96)
Death or Transplantation
(n ¼ 317)
Persistently Abnormal
(n ¼ 328) p Value
Follow-up since diagnosis, median,
months
9.5 3.2 17.7 –
Age at diagnosis
Mean  SD, yrs 2.4  4.0 5.4  6.0 3.7  5.3 <0.001
Median, yrs 0.93 1.67 0.91 <0.001
Age group, % <0.001
<1 yrs 55.2 42.9 53.4
1–10 yrs 35.4 26.8 29.3
>10 yrs 9.4 30.3 17.4
Height-for-age, mean  SD, z-score –0.64  1.74
(n ¼ 47)
–0.52  1.69
(n ¼ 193)
–0.32  1.48
(n ¼ 208)
0.30
Race, % 0.07
White 53.8 55.6 53.7
Black 16.1 23.8 22.2
Hispanic 25.8 15.2 15.1
Other 4.3 5.4 9.0
Male, % 43.8 49.2 45.4 0.50
Era of diagnosis, % 0.50
1990–1999 60.4 62.5 57.9
2000–2010 39.6 37.5 42.1
Congestive heart failure at diagnosis, % 74.0 88.3 69.4 <0.001
DCM ¼ dilated cardiomyopathy.
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140845 children underwent heart transplantation or died outside
the 2-year analysis window, during a median follow-up time
of 3 years from diagnosis.
In the 317 children in the death/transplantation group,
104 died and 213 underwent heart transplantation within
2 years after diagnosis of idiopathic DCM. In these 317Table 2
Left Ventricular Echocardiographic Proﬁle
and Abnormal Left Ventricular Function an
Echocardiographic Status or Clinical Outco
Normalized
(n ¼ 96)
Death
LV dimension, mean  SD, z-score
EDD 4.56  1.87
ESD 6.39  2.03
(n ¼ 87)
LVFS
Mean  SD, z-score –9.21  2.86
(n ¼ 90)
–
Mean  SD, % 15.4  6.9
LVWT, mean  SD, z-score
Posterior –0.16  2.29
(n ¼ 81)
–
Septal –0.77  1.46
(n ¼ 79)
–
Mass, mean  SD, z-score 2.71  1.85
(n ¼ 81)
PWD:EDD ratio, mean  SD 0.13  0.04
(n ¼ 81)
Ratio PWT:EDD z-score –1.80  1.48
(n ¼ 81)
–
DCM ¼ dilated cardiomyopathy; EDD ¼ end-diastolic dimension; ESD ¼ end-sys
ventricular wall thickness; PWT ¼ posterior wall thickness.children, the median time to death or transplantation was 3
months after diagnosis.
Predictors at diagnosis of echocardiographic normalization.
On univariate analysis, z-scores for LVEDD, LVESD,
LVFS, and LV mass were associated with normalization
(Table 4). Multivariate analysis identiﬁed age at diagnosisat Diagnosis in Children With Idiopathic DCM
d Dilation at Diagnosis (N ¼ 741), by
me Within 2 Years After Diagnosis
or Transplantation
(n ¼ 317)
Persistently Abnormal
(n ¼ 328) p Value
5.70  2.06 5.41  2.06 <0.001
7.69  1.95
(n ¼ 287)
7.20  2.09
(n ¼ 293)
<0.001
10.28  2.28
(n ¼ 297)
–9.34  2.81
(n ¼ 313)
<0.001
11.4  4.9 14.7  6.3 <0.001
0.39  2.57
(n ¼ 238)
–0.45  2.56
(n ¼ 257)
0.65
0.94  1.73
(n ¼ 217)
–0.88  1.88
(n ¼ 240)
0.77
3.42  2.53
(n ¼ 238)
3.11  2.23
(n ¼ 257)
0.046
0.12  0.07
(n ¼ 238)
0.12  0.04
(n ¼ 257)
0.18
2.23  2.31
(n ¼ 238)
–2.17  1.48
(n ¼ 257)
0.18
tolic dimension; LVFS ¼ left ventricular fractional shortening; LVWT ¼ left
Table 3
Left Ventricular Echocardiographic Proﬁle From Time of Cardiomyopathy Diagnosis to 2 Years in Children With Idiopathic Dilated
Cardiomyopathy and Abnormal Left Ventricular Function and Dilation at Diagnosis (N ¼ 741), by Echocardiographic Status
or Clinical Outcome Within 2 Years After Diagnosis
Normalized Death or Transplant Persistently Abnormal
At Diagnosis
(n ¼ 96)
Follow-Up
Echocardiogram*
(n ¼ 96)
At Diagnosis
(n ¼ 317)
Follow-Up
Echocardiogram*
(n ¼ 202)
At Diagnosis
(n ¼ 328)
Follow-Up
Echocardiogram*
(n ¼ 328)
LV dimension, z-score
EDD 4.56  1.87 –0.06  4.25 5.70  2.06 6.05  2.34 5.41  2.06 3.43  2.63
ESD 6.39  2.03 –0.17  3.56 7.69  1.95 7.79  2.37 7.20  2.09 4.40  3.06
LVFS
z-score –9.21  2.86 –0.08  1.74 –10.28  2.28 –9.79  3.14 –9.34  2.81 –5.49  3.67
% 15.40  6.88 37.12  4.76 11.44  4.92 12.60  7.19 14.65  6.33 23.16  9.14
LVWT, z-score
PWT –0.16  2.29 –0.58  1.84 –0.39  2.57 0.15  2.29 –0.45  2.56 –0.74  2.64
SWT –0.77  1.46 –0.53  1.40 –0.94  1.73 –0.75  1.49 –0.88  1.88 –0.81  1.90
Mass, z-score 2.71  1.85 –0.35  1.83 3.42  2.53 3.89  2.44 3.11  2.23 1.55  2.60
PWT:EDD
Ratio 0.13  0.04 0.18  0.13 0.12  0.07 0.13  0.05 0.12  0.04 0.14  0.08
z-score –1.80  1.48 –0.26  4.66 –2.23  2.31 –1.94  1.88 –2.17  1.48 –1.62  2.63
Values are mean  SD. *Follow-up echocardiogram deﬁned as the ﬁrst occurrence of normalization in the normalized group; the latest echocardiogram before death/transplantation in the
death/transplantation group; or the latest echocardiogram within 2 years following diagnosis in the persistently abnormal group.
Abbreviations as in Table 2.
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1409(hazard ratio: 0.92; 95% conﬁdence interval: 0.88 to 0.97)
and LV dilation (a lower LVEDD z-score; i.e., closer to
normal; hazard ratio: 0.78; 95% conﬁdence interval 0.70 to
0.87) as the 2 independent factors associated with a higherFigure 2
Cumulative Incidence of Echocardiographic
Normalization in Children With Idiopathic DCM
(N ¼ 741), in the Presence of the Competing Risk
for Death or Transplantation
At any given time point, the estimated cumulative incidence rates associated with
the 3 states totals to 1.0. At 2 years, 22% of children had normal echocardio-
graphic values, 51% had died or undergone transplantation, and 27% remained
abnormal with respect to LV size and function.likelihood of recovering normal LV size and function by
echocardiogram within 2 years after diagnosis. For each 1-
year decrease in age at diagnosis, children were 1.1-fold
more likely to recover normal LV size and function within
2 years of diagnosis (hazard ratio [HR]) (95% CI: 1.05 to
1.16; p < 0.001). For every 1-unit decrease in LVEDD z-
score, the likelihood of recovering normal LV size and
function within 2 years of diagnosis was 1.3-fold higher
(HR) (95% CI: 1.19 to 1.47; p < 0.001).
Cumulative incidences of recovering normal LV size and
function by age are shown in Figure 3. Younger age at
diagnosis, as both a continuous and a categorical variable
(<1, 1–10, or >10 years), was associated with a higher
incidence of normalization (p < 0.001 and p ¼ 0.008,
respectively). Normalization by 2 years was achieved in 24%
of infants and in 26% of children aged 1 to 10 years, but in
only 10% of those diagnosed after age 10 years. Figure 4
shows the cumulative incidences of having a normal echo
within 2 years of diagnosis on the basis of LVEDD z-score
at diagnosis. Normalization with respect to LV size and
function was achieved in 30% of children with LVEDD
z-scores in the lowest tertile (<4.29), in 21% of those in the
middle tertile, and in 13% of those with LVEDD z-score in
the highest tertile (6.29). Event probabilities were similar
when displayed according to LVESD z-score.
We conducted a sensitivity analysis to assess whether
potential misclassiﬁcation arising from the use of follow-up
echocardiograms obtained before but not precisely at the
2-year time target affected the robustness of the multivariate
model. Of the 328 children classiﬁed as having persistently
abnormal echocardiograms, 204 had an echocardiogram
beyond the 2-year time period of interest. No subsequent
echocardiograms were available in 124 children classiﬁed as
Table 4
Hazard Ratios From Univariate Cox Regression
Analysis of Possible Predictors of Echocardiographic
Normalization in Children With Idiopathic Dilated
Cardiomyopathy and Abnormal Left Ventricular
Function and Dilation at Diagnosis (N ¼ 741)
Characteristic at Diagnosis Hazard Ratio (95% CI) p Value
Age (N ¼ 741), yrs* 0.92 (0.88–0.97) <0.001
Age group 0.008
<1 yrs 2.77 (1.38–5.57)
1–10 yrs 3.05 (1.48–6.28)
>10 yrs Reference
Male (N ¼ 741) 0.88 (0.59–1.31) 0.52
Body surface area z-score (n ¼ 715) 1.11 (0.97–1.27) 0.12
Height-for-age z-score (n ¼ 448) 0.92 (0.78–1.09) 0.35
Race (N ¼ 741) 0.07
White 0.94 (0.42–2.10)
Black 0.65 (0.27–1.61)
Hispanic 1.49 (0.64–3.49)
Other Reference
Era of diagnosis (N ¼ 741) 0.93
1990–1999 1.02 (0.65–1.47)
2000–2010 Reference
Congestive heart failure (n ¼ 740) 0.84 (0.53–1.31) 0.44
Family history
Cardiomyopathy (n ¼ 454) 0.79 (0.39–1.60) 0.51
Sudden death (n ¼ 462) 0.62 (0.19–2.03) 0.43
LV dimension
EDD (N ¼ 741)
z-score* 0.78 (0.70–0.87) <0.001
Tertile <0.001
<4.29 2.67 (1.58–4.50)
4.29 to <6.29 1.56 (0.89–2.76)
6.29 Reference
ESD (n ¼ 667)
z-score 0.78 (0.70–0.87) <0.001
Tertile <0.001
<6.26 3.48 (1.98–6.12)
6.26 to <8.17 1.59 (0.85–3.00)
8.17 Reference
LVFS (n ¼ 700)
z-score 1.08 (1.00–1.17) 0.041
Tertile 0.31
<–11.1 0.72 (0.44–1.19)
–11.1 to <–8.99 0.73 (0.44–1.18)
–8.99 Reference
Continued in the next column
Table 4 Continued
Characteristic at Diagnosis Hazard Ratio (95% CI) p Value
LVWT z-score
Posterior (n ¼ 576) 1.04 (0.96–1.12) 0.37
Septal (n ¼ 536) 1.04 (0.94–1.16) 0.42
LV mass (n ¼ 576)
z-score 0.90 (0.83–0.98) 0.019
Tertile 0.23
<2.04 1.57 (0.90–2.74)
2.04 to <4.00 1.50 (0.87–2.61)
 4.00 Reference
PWT:EDD ratio (n ¼ 576)
Log (PWT:EDD ratio) 2.09 (1.24–3.53) 0.006
Tertile 0.009
<–2.30 0.40 (0.22–0.72)
–2.30 to <–2.04 0.79 (0.49–1.29)
–2.04 Reference
*Age at diagnosis and EDD z-score at diagnosis composed the ﬁnal multivariate model for time to
echo normalization (both terms, p < 0.001).
Abbreviations as in Table 2.
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1410persistently abnormal. As a worst-case scenario with regard
to misclassiﬁcation, we reclassiﬁed these 156 children (32 þ
124) as having normalized by 2 years after diagnosis,
resulting in 317 with death/heart transplantation, 252 with
normalization, and 172 with persistently abnormal echo-
cardiograms. We obtained nearly the same multivariate
model: it included age at diagnosis (HR: 0.90; 95% CI: 0.86
to 0.94; p < 0.001) and LVESD z-score (HR: 0.73; 95%
CI: 0.65 to 0.81; p < 0.001).
Medical therapy. Only the presence or absence of anti-
congestive medication use was collected throughout thestudy period. The proportion of children receiving anti-
congestive medications at the time of diagnosis did not differ
between groups: 85 of 96 (89%) in the normalized group,
284 of 317 (90%) in the death/transplantation group, and
293 of 328 (89%) in the persistently abnormal group.
However, the proportion of children on anticongestive
therapy at the time of the last echocardiogram within 2 years
did differ signiﬁcantly between groups (p < 0.001), with the
highest usage in the death/heart transplantation group (210
of 213 [99%] vs. 83/96 [87%] in the normalized group and
284 of 328 [87%] in the persistently abnormal group).Discussion
We report the 2-year cumulative incidence of recovery of
normal LV size and function in children with idiopathic
DCM from a large multicenter pediatric cardiomyopathy
registry. Although half of the nearly 800 children died or
underwent heart transplantation within 2 years of presen-
tation, 9% did recover normal LV size and function by 1 year
and 22% by 2 years, with a median time to normalization of
9 months. Younger age and less LV dilation at diagnosis
independently predicted normalization within 2 years of
presentation. However, 9% of the children who recovered
normal echocardiographic function within 2 years later died
or underwent heart transplantation.
Several studies have reported improved cardiac function in
some children with DCM. The incidence of cardiac
improvement ranges from 16% to 63%, depending on the
deﬁnition of improvement and the cause of DCM (3,16–19).
In a prospective multicenter carvedilol trial in children with
heart failure, of 93 children with DCM, 59 (63%) had better
New York Heart Association class or Ross heart failure stage
at 6-month follow-up (16).
Figure 3 Cumulative Incidence of Echocardiographic Normalization in Children With Idiopathic DCM (N ¼ 741), by Age at Diagnosis
Estimated cumulative incidence rates of recovery of normal echocardiographic function and size was similar in the 2 younger age groups (24% for those diagnosed before age 1
year [A] and 26% in those diagnosed before between ages 1 and 10 years [B]) and was lowest in children diagnosed after age 10 years (10% by age 2 years [C]). Black lines
indicate echocardiographic normalization; red lines indicate death or transplantation; green lines indicate persistently abnormal ﬁndings on echocardiography.
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1411Not surprisingly, our rate of cardiac improvement, deﬁned
as normal LV size and function by echocardiographic
assessment, was lower than that in studies deﬁning cardiac
improvement as the resolution of heart failure symptoms. In
an earlier single-center retrospective series by Lewis et al.
(3), of 63 children with idiopathic DCM, 25% had normal
LV function at follow-up. That study was similar to ours in
that children with myocarditis and other known causes of
DCM were excluded; all included patients had both
depressed LV function and LV dilation at presentation, and
the endpoint was recovery of LV function by echocardio-
graphic measurement. In a recent report from the Australian
National Population–based Study of Childhood Cardio-
myopathy (20), the incidence of recovering normal echo-
cardiographic LV function and size in children with DCM
due to a variety of causes was 33% at 15 years. Although
both of the aforementioned studies showed higher rates of
normalization, this difference may have been due to the
longer durations of follow-up (mean: 7 and 15 years [3,20]).
Additionally, when those with a known cause for DCM are
excluded, the rate of echocardiographic normalization in the
Australian cohort is consistent with our ﬁnding, with
normalization occurring in approximately 20% at 2 years
among the 27 children with idiopathic DCM (20).
Younger age at diagnosis, speciﬁcally prior to age 10 years,
predicted recovery of normal echocardiographic function
and size within 2 years of presentation. Younger age haspredicted cardiac recovery in other studies of pediatric DCM
as well. Lewis et al. (3) found that children who recov-
ered normal function were younger than those with persis-
tently abnormal function (age: 2.1  1.8 years vs. 4.5  5.9
years).
Less LV dilation at presentation was the other indepen-
dent predictor of recovering normal LV size and function
within 2 years of presentation. Although at diagnosis our
normalized group had a mean LVEDD z-score that was
closer to normal than those of the other groups, the LV was,
nonetheless, markedly dilated at presentation, with a mean
z-score of 4.56 (1.87). Previously reported single-center
series have had relatively small numbers of patients and
have not found any echo parameters at presentation pre-
dictive of recovery, which may have been due to limited
power (3,18). Our analysis contributes new information.
A previous PCMR report found that a higher LVEDD
z-score at diagnosis was associated with transplantation but
not with mortality in DCM from all causes (7). Knowing
that heart transplantation affects the natural history of
idiopathic DCM and competing outcomes, our ﬁnding of
normal LV size and function in 22% of children by 2 years
draws attention to the possibility for myocardial recovery
even in children with marked LV dilation at presentation.
Nonetheless, longer follow-up is necessary because some of
these children (n ¼ 9) later died or underwent heart trans-
plantation for recurrent heart failure.
Figure 4
Cumulative Incidence of Echocardiographic Normalization in Children With Idiopathic DCM (N ¼ 741),
by EDD z-Score Tertile From the Time of Diagnosis
Children with lower end-diastolic dimension (EDD) z-scores at diagnosis were more likely to have recovered normal cardiac function by age 2 years (30% in those with EDD
z-scores <4.29 [A]; 21% in those with scores in the middle tertile [B]; and 13% in those with scores 6.29 [C]). Black lines indicate echocardiographic normalization; red lines
indicate death or transplantation; green lines indicate persistently abnormal ﬁndings on echocardiography.
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1412This analysis was not designed to address the need for
long-term follow-up or continued medical therapy in chil-
dren recovering LV size and function. Most of these chil-
dren were still receiving anticongestive medications at the
time of the follow-up echocardiogram. The impact of the
withdrawal of these medications on outcome could not be
ascertained from this observational dataset.
An area of study is to identify children with full cardiac
recovery in terms of normal diastolic function, normal car-
diac magnetic resonance imaging results without residual
inﬂammation or ﬁbrosis, absence of an arrhythmogenic
substrate, and normal LV size and function. In our study,
some of the children with normal LV size and function at
follow-up did later undergo heart transplantation, and 10 of
51 normalized cases that had follow-up data past 2 years had
later abnormal LV size or function without recurring
normalization. In the Australian report, none of those with
normal LV size and function at follow-up had subsequent
decreased function, death, or transplantation (20). Thus, the
question remains as to who requires ongoing follow-up or
medical therapy. Are these children at risk for recurrent heart
failure, or is it only a subset of children at risk who have
persistent abnormalities? How much change over time in LV
size and function is natural variation or is due to a change in
ventricular loading or geometry with alterations in medical
therapy? Understanding this cardiac recovery versusremission further and predicting the impact of genotypic or
genetic modiﬁers on prognosis, response to medical therapy,
and response to ventricular assist support in children with the
potential for cardiac recovery are key goals of future research.
Study limitations. The strength of the PCMR was the
collaboration of 98 pediatric cardiac centers across the
United States and Canada to collect data on children with
DCM over 20 years. Importantly, serial echocardiograms
collected during this observational study made this analysis
possible. Nonetheless, the lack of standardized follow-up
and time at which echocardiograms were obtained was a
limitation. The echocardiographic data collected were
abstracted annually, recording the latest echocardiographic
ﬁndings from each year. Thus, the timing was left-censored,
with some children classiﬁed as having a normal echo-
cardiogram at 2-year follow-up, but the normalization could
have occurred earlier, and the time-to-recovery values in this
report may have been overestimates. However, our sensi-
tivity analysis indicated that our ﬁndings were robust to
reclassiﬁcation of patients who had additional follow-up
data, and in practice, many patients may not undergo
echocardiograms more than annually.
Another limitation was that 15% of subjects known to
have had abnormal LV function and dilation at diagnosis
were excluded from analysis due to insufﬁcient follow-
up information. We found that these 127 patients were
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1413slightly older at diagnosis than were the 741 analyzed.
Therefore, because younger age at diagnosis was associated
with earlier time to echo normalization, our reported re-
covery rates may have been mildly overestimated with respect
to true rates in the pediatric idiopathic DCM population.
Information on the presence of tricuspid or mitral
regurgitation and family history of sudden death or heart
disease was available in only a few children, so these variables
could not be included as candidate predictors in the multi-
variate model. Lastly, information related to medication use,
such as beta-blockers and angiotensin-converting enzyme
inhibitors, was insufﬁcient for analysis of the association
between medical therapy and recovery of normal echocar-
diographic function; or between discontinuation of therapy
and outcome.
Conclusions
Despite marked LV dilation at presentation, 22% of children
with idiopathic DCM recovered normal LV size and func-
tion within 2 years. Younger age and less LV dilation at
diagnosis independently predicted normalization within 2
years of presentation. This improvement in cardiac function
and size was not sustained in all children, which suggests
that other indicators of cardiac recovery need to be explored,
that longer follow-up may be required for some children, or
that medical therapy may need to be continued beyond the
recovery of normal LV size and function. Investigations
related to predictors of cardiac recovery, such as genetic as-
sociations and outcomes, markers for cardiac recovery versus
remission, and the impact of long-term medical therapy or
ventricular unloading with ventricular assist devices in chil-
dren with idiopathic DCM are important next steps.
Reprint requests and correspondence: Dr. Melanie D. Everitt,
Primary Children’s Medical Center, University of Utah, Division
of Cardiology, Suite 1500, 100 North Mario Capecchi Drive, Salt
Lake City, Utah 84113. E-mail: Melanie.everitt@imail.org.REFERENCES
1. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med
1994;331:1564–75.
2. Maron BJ, Towbin JA, Thiene G, et al. Contemporary deﬁnitions
and classiﬁcation of the cardiomyopathies. Circulation 2006;113:
1807–16.3. Lewis AB. Late recovery of ventricular function in children with
idiopathic dilated cardiomyopathy. Am Heart J 1999;138:334–8.
4. Foerster SR, Canter CE, Cinar A, et al. Ventricular remodeling and
survival are more favorable for myocarditis than for idiopathic dilated
cardiomyopathy in childhood: an outcomes study from the Pediatric
Cardiomyopathy Registry. Circ Heart Fail 2010;3:689–97.
5. Matsumura Y, Hoshikawa-Nagai E, Kubo T, et al. Left ventricular
reverse remodeling in long-term (>12 years) survivors with idiopathic
dilated cardiomyopathy. Am J Cardiol 2013;111:106–10.
6. Redﬁeld MM, Gersh BJ, Bailey KR, Ballard DJ, Rodeheffer RJ.
Natural history of idiopathic dilated cardiomyopathy: effect of referral
bias and secular trend. J Am Coll Cardiol 1993;22:1921–6.
7. Alvarez JA, Orav EJ, Wilkinson JD, et al. Competing risks for death
and cardiac transplantation in children with dilated cardiomyopathy:
results from the Pediatric Cardiomyopathy Registry. Circulation 2011;
124:814–23.
8. Singh TP, Sleeper LA, Lipshultz S, et al. Association of left ventricular
dilation at listing for heart transplant with postlisting and early post-
transplant mortality in children with dilated cardiomyopathy. Circ
Heart Fail 2009;2:591–8.
9. Azevedo VM, Santos MA, Albanesi Filho FM, Castier MB, Tura BR,
Amino JG. Outcome factors of idiopathic dilated cardiomyopathy in
children- a long-term follow-up review. Cardiol Young 2007;17:
175–84.
10. Sluysmans T, Colan SD. Theoretical and empirical derivation of car-
diovascular allometric relationships in children. J Appl Physiol 2005;99:
445–57.
11. Friedman RA, Moak JP, Garson A Jr. Clinical course of idiopathic
dilated cardiomyopathy in children. J Am Coll Cardiol 1991;18:152–6.
12. Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and out-
comes of dilated cardiomyopathy in children. JAMA 2006;296:
1867–76.
13. Grenier MA, Osganian SK, Cox GF, et al. Design and implementation
of the North American Pediatric Cardiomyopathy Registry. Am Heart
J 2000;139:S86–95.
14. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric
cardiomyopathy in two regions of the United States. N Engl J Med
2003;348:1647–55.
15. Fine JP, Gray RJ. A proportional hazards model for the subdistribution
of a competing risk. J Am Statistical Assoc 1999;94:496–509.
16. Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and
adolescents with heart failure: a randomized controlled trial. JAMA
2007;298:1171–9.
17. Daubeney PEF, Nugent AW, Chondros P, et al. Clinical features and
outcomes of childhood dilated cardiomyopathy: results from a national
population-based study. Circulation 2006;114:2671–8.
18. O’Sullivan JJ, Roche SL, Crossland DS, et al. Recovery of heart
function in children with acute severe heart failure. Transplantation
2008;85:975–9.
19. Taliercio CP, Seward JB, Driscoll DJ, et al. Idiopathic dilated car-
diomyopathy in the young: clinical proﬁle and natural history. J Am
Coll Cardiol 1985;6:1126–31.
20. Alexander PM, Daubeney PE, Nugent AW, et al., National Australian
Childhood Cardiomyopathy Study Group. Long-term outcomes of
dilated cardiomyopathy diagnosed during childhood: results from a
national population-based study of childhood cardiomyopathy. Circu-
lation 2013;128:2039–46.
Key Words: cardiomyopathy - echocardiography - heart failure -
pediatrics.
